Use of Voclosporin in Pediatric Patients: Summary of Available data from Post-Marketing Reports Physician and Clinical Researcher in Rheumatology (UKKW 2026) - Mar 16, 2026 - Abstract #THK8; Pres time: Mar 12, 2026; 10:00 AM - 11:00 AM; Location: HALL Q; P3 | " Due to the limited number of reports and incomplete nature of spontaneous reporting, the emerging safety profile of voclosporin in pediatric patients requires further investigation, although no new safety signals were detected. Additional research is needed to better characterize the use of voclosporin in this population."
Clinical • P4 data • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Pediatrics • Renal Disease • Rheumatology • Systemic Lupus Erythematosus
|
|
Chock Eugenia1; Pediatric Nephrology Research Fellow Daga Ankana2; Clinical Scientist, Clinical Development Begum Tasim3; Senior Medical Director, Medical Affairs Dao Kathryn3; Sadiq Ahmed, Clinical Operations Manager Dardeno Michelle3
|